Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07819435
PHASE2/PHASE3
Phase 2/3 Efficacy and Safety of PP405 in Adult Males
Sponsor: Pelage Pharmaceuticals, Inc.
View on ClinicalTrials.gov
Summary
The study is designed to validate efficacy and long term safety of PP405.
Official title: A Randomized, Multicenter, Double-blind, Vehicle-controlled, Phase 2/3 Study to Assess Efficacy and Long-Term Safety of PP405 in Adult Males With Androgenetic Alopecia
Key Details
Gender
MALE
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
600
Start Date
2026-09
Completion Date
2028-06
Last Updated
2026-09-18
Healthy Volunteers
No
Conditions
Interventions
DRUG
PP405 0.05% Topical Gel
Medicated topical gel containing PP405 0.05%
DRUG
Vehicle Topical Gel
Topical gel